Healthcare provider profile · identity verified

Peter Joseph Mccarthy, D.O.

Family Practice · MECHANICSBURG, PA · NPI 1902124506

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	442	158
Amlodipine Besylate	Amlodipine Besylate	319	100
Lisinopril	Lisinopril	201	74
Levothyroxine Sodium	Levothyroxine Sodium	190	61
Rosuvastatin Calcium	Rosuvastatin Calcium	143	56
Metoprolol Succinate	Metoprolol Succinate	135	40
Losartan Potassium	Losartan Potassium	133	44
Pantoprazole Sodium	Pantoprazole Sodium	118	51
Hydrochlorothiazide	Hydrochlorothiazide	105	33
Metformin Hcl Er	Metformin Hcl	89	29
Simvastatin	Simvastatin	89	30
Eliquis	Apixaban	81	21
Tamsulosin Hcl	Tamsulosin Hcl	81	31
Gabapentin	Gabapentin	79	28
Allopurinol	Allopurinol	72	25
Metformin Hcl	Metformin Hcl	71	28
Sertraline Hcl	Sertraline Hcl	69	28
Metoprolol Tartrate	Metoprolol Tartrate	65	20
Furosemide	Furosemide	62	23
Omeprazole	Omeprazole	62	23
Montelukast Sodium	Montelukast Sodium	59	24
Pravastatin Sodium	Pravastatin Sodium	57	19
Clopidogrel	Clopidogrel Bisulfate	55	16
Trazodone Hcl	Trazodone Hcl	55	24
Escitalopram Oxalate	Escitalopram Oxalate	50	17
Prednisone	Prednisone	50	45
Lorazepam	Lorazepam	46	14
Olmesartan Medoxomil	Olmesartan Medoxomil	44	13
Synthroid	Levothyroxine Sodium	44	14
Famotidine	Famotidine	42	16
Bupropion Xl	Bupropion Hcl	41	13
Ezetimibe	Ezetimibe	41	suppressed
Fluticasone Propionate	Fluticasone Propionate	39	22
Trulicity	Dulaglutide	37	suppressed
Carvedilol	Carvedilol	36	13
Potassium Chloride	Potassium Chloride	36	11
Glimepiride	Glimepiride	34	13
Jardiance	Empagliflozin	34	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	34	12
Clonazepam	Clonazepam	33	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	29	22
Atenolol	Atenolol	27	suppressed
Chlorthalidone	Chlorthalidone	27	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	27	suppressed
Duloxetine Hcl	Duloxetine Hcl	26	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	24	suppressed
Glipizide	Glipizide	23	suppressed
Buspirone Hcl	Buspirone Hcl	22	suppressed
Glipizide Er	Glipizide	22	suppressed
Valsartan	Valsartan	22	suppressed
Ramipril	Ramipril	21	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	20	16
Cephalexin	Cephalexin	19	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	suppressed
Meloxicam	Meloxicam	19	12
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	18	18
Alprazolam	Alprazolam	18	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	17
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	17	17
Mirtazapine	Mirtazapine	17	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Pregabalin	Pregabalin	16	suppressed
Alendronate Sodium	Alendronate Sodium	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Nystatin	Nystatin	15	suppressed
Tradjenta	Linagliptin	15	suppressed
Verapamil Sr	Verapamil Hcl	15	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	14	suppressed
Azithromycin	Azithromycin	14	14
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Spironolactone	Spironolactone	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	13
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Latanoprost	Latanoprost	12	suppressed
Mounjaro	Tirzepatide	12	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Tramadol Hcl	Tramadol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error